LEP and breast carcinoma: Plasma leptin data have to be interpreted with caution since leptin and the two main isoforms of its receptor have been reported to be expressed in 84% of breast cancers suggesting that cells within tumors can respond to leptin via autocrine as well as paracrine and endocrine pathways [67].